Tag: c_difficile

Antiviral Drug Fails to Improve Long COVID Symptoms in NIH Trial

29 Sep 2026 3:30 p.m. · Source: NIH RESEARCH MATTERS

A clinical trial found a common antiviral drug given for up to 25 days did not improve Long COVID symptoms. Other NIH Research Matters studies cover cystic fibrosis tRNA treatment and C. difficile in newborn mice.

Health Science & Technology Medical Science General Politics Federal Government USA Long COVID antiviral drug clinical trial cystic fibrosis transfer RNA C. difficile NIH Research Matters